Xspray Pharma AB (publ) (STO:XSPRAY)
10.18
-0.30 (-2.86%)
Nov 20, 2026, 5:29 PM CET
Xspray Pharma AB Employees
Xspray Pharma AB had 24 employees as of September 30, 2026. The number of employees decreased by 2 or 7.69% compared to the same quarter last year. That makes Xspray Pharma AB the 37,863rd largest employer in the world and 555th in Sweden.
Employees
24
Change (1Y)
-2
Growth (1Y)
-7.69%
Revenue / Employee
299.50K SEK
Profits / Employee
-6.31M SEK
Market Cap
482.70M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2026 | 24 | -2 | -7.69% |
| Jun 30, 2026 | 24 | -2 | -7.69% |
| Mar 31, 2026 | 24 | -2 | -7.69% |
| Dec 31, 2025 | 25 | -2 | -7.41% |
| Sep 30, 2025 | 26 | 2 | 8.33% |
| Jun 30, 2025 | 26 | 0 | - |
| Mar 31, 2025 | 26 | 0 | - |
| Dec 31, 2024 | 27 | 1 | 3.85% |
| Sep 30, 2024 | 24 | -2 | -7.69% |
| Jun 30, 2024 | 26 | 0 | - |
| Mar 31, 2024 | 26 | 0 | - |
| Dec 31, 2023 | 26 | -1 | -3.70% |
| Sep 30, 2023 | 26 | 0 | - |
| Jun 30, 2023 | 26 | 1 | 4.00% |
| Mar 31, 2023 | 26 | 2 | 8.33% |
| Dec 31, 2022 | 27 | 4 | 17.39% |
| Sep 30, 2022 | 26 | 4 | 18.18% |
| Jun 30, 2022 | 25 | 3 | 13.64% |
| Mar 31, 2022 | 24 | 3 | 14.29% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Oncopeptides AB | 71 |
| Sprint Bioscience AB | 33 |
| Cantargia AB | 22 |
| Intervacc AB | 16 |
| Corline Biomedical AB | 14 |
| AlzeCure Pharma AB | 10 |
| SynAct Pharma AB | 8 |
| Medivir AB | 7 |
Xspray Pharma AB News
- 16 days ago - Xspray Pharma AB Quarterly report: Q3 2026 - Filings
- 18 days ago - Xspray Pharma AB Transcript: BioStock Life Science Summit 2026 - Transcripts
- 3 months ago - Xspray Pharma AB Transcript: FDA announcement - Transcripts
- 3 months ago - Xspray Pharma AB Press release: FDA announcement - Filings
- 3 months ago - Xspray Pharma AB Quarterly report: Q2 2026 - Filings
- 6 months ago - Xspray Pharma AB Quarterly report: Q1 2026 - Filings
- 9 months ago - Xspray Pharma AB Annual report: Q4 2025 - Filings
- 9 months ago - Xspray Pharma AB Quarterly report: Q4 2025 - Filings